New Atlas Maps How 87 Signaling Molecules Shape Human Heart Function
Cardiopedia-Ligand reveals how ligands drive heart failure states, spotlighting an interferon-γ signature in HFpEF.
Summary
Researchers at QIMR Berghofer created Cardiopedia-Ligand, a first-of-its-kind atlas that tested 87 signaling molecules on human cardiac organoids — tiny lab-grown heart models — measuring both how they contract and how their genes respond. Using high-throughput automation and single-organoid RNA sequencing, the team identified distinct functional clusters including inotropes, inflammatory signals, and extracellular matrix regulators. Machine learning then cross-referenced these clusters against real heart failure biopsy samples, uncovering a previously underappreciated interferon-γ signaling pathway linked to heart failure with preserved ejection fraction (HFpEF) — a common, poorly treated form of heart failure especially prevalent in older adults. This open resource gives researchers and clinicians a powerful map for discovering new cardiac drug targets.
Detailed Summary
Heart disease remains a leading cause of death and disability in aging populations, yet drug discovery for cardiac conditions has been hampered by the lack of comprehensive, human-relevant reference datasets that simultaneously capture functional and molecular responses. Cardiopedia-Ligand addresses this gap directly.
The research team stimulated human cardiac organoids (hCOs) with 87 ligands targeting 98 cell-membrane receptors known to be expressed in the human heart. These organoids serve as miniaturized, three-dimensional models that replicate key aspects of cardiac biology more faithfully than flat cell cultures. An automated high-throughput pipeline enabled individualized contractility measurements alongside single-organoid mRNA sequencing — capturing both what the heart does and what genes drive that behavior simultaneously.
Analysis revealed multiple functional and transcriptional clusters, some well-characterized (inotropes, endothelin peptides, ECM regulators) and others previously unrecognized. Critically, machine learning applied to these clusters and cross-referenced against human heart failure biopsies identified an interferon-γ signaling signature strongly associated with heart failure with preserved ejection fraction (HFpEF). HFpEF disproportionately affects older adults and women, and current treatments remain limited — making this mechanistic finding particularly significant.
The dataset also revealed previously unappreciated similarities between distinct ligands, suggesting that some drugs or biological signals may have overlapping cardiac effects that weren't recognized from single-endpoint studies. The 'fingerprinting' approach — matching organoid transcriptional states to disease biopsies — offers a scalable method for identifying disease-relevant signaling pathways and potential therapeutic targets.
Limitations include that the study used organoids rather than intact human hearts, and findings are derived from the abstract alone. Nonetheless, Cardiopedia-Ligand represents a transformative open resource for cardiac biology, with direct implications for aging-related heart disease research and drug development.
Key Findings
- 87 ligands targeting 98 cardiac receptors were systematically profiled in human cardiac organoids for the first time.
- An interferon-γ signaling signature was identified as a driver of heart failure with preserved ejection fraction (HFpEF).
- Machine learning fingerprinting matched organoid transcriptional states to real human heart failure biopsies.
- Multiple previously unrecognized functional and inflammatory clusters were discovered beyond known inotrope and ECM groups.
- The open-access atlas provides a scalable platform for identifying new cardiac drug targets relevant to aging.
Methodology
Human cardiac organoids were stimulated with 87 ligands covering 98 cell-membrane receptors. An automated high-throughput pipeline combined individualized contractility measurements with single-organoid mRNA sequencing. Clustering analysis and machine learning were used to cross-reference organoid states with human heart failure biopsy data.
Study Limitations
Findings are based on cardiac organoids, which approximate but do not fully replicate the complexity of intact human heart tissue or systemic physiology. The summary is based on the abstract only, as the full text was not available, limiting detailed methodological assessment. Potential conflicts of interest exist, as several authors hold patents and equity stakes in companies commercializing cardiac organoid technology.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: